Page last updated: 2024-11-05

zolpidem and Obstructive Lung Diseases

zolpidem has been researched along with Obstructive Lung Diseases in 3 studies

Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Murciano, D2
Armengaud, MH1
Cramer, PH1
Neveux, E1
L'Héritier, C1
Pariente, R2
Aubier, M2
Girault, C1
Muir, JF1
Mihaltan, F1
Borderies, P1
De La Giclais, B1
Verdure, A1
Samson-Dollfus, D1
Palacios, S1

Trials

2 trials available for zolpidem and Obstructive Lung Diseases

ArticleYear
Acute effects of zolpidem, triazolam and flunitrazepam on arterial blood gases and control of breathing in severe COPD.
    The European respiratory journal, 1993, Volume: 6, Issue:5

    Topics: Blood Gas Analysis; Carbon Dioxide; Flunitrazepam; Humans; Hypnotics and Sedatives; Lung Diseases, O

1993
Effects of repeated administration of zolpidem on sleep, diurnal and nocturnal respiratory function, vigilance, and physical performance in patients with COPD.
    Chest, 1996, Volume: 110, Issue:5

    Topics: Administration, Oral; Aged; Ambulatory Care; Arousal; Bronchodilator Agents; Carbon Dioxide; Circadi

1996

Other Studies

1 other study available for zolpidem and Obstructive Lung Diseases

ArticleYear
Comparison of zolpidem (Z), triazolam (T), and flunitrazepam (F) effects on arterial blood gases and control of breathing in patients with severe chronic obstructive pulmonary disease (COPD).
    Chest, 1990, Volume: 97, Issue:3 Suppl

    Topics: Flunitrazepam; Humans; Hypnotics and Sedatives; Lung Diseases, Obstructive; Pyridines; Respiratory C

1990